Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia

This study compared the clinical outcomes and safety of meropenem–colistin versus meropenem–tigecycline in the treatment of adult patients with carbapenem-resistant Acinetobacter baumannii (CRAB) pneumonia. A retrospective observational study of patients with CRAB pneumonia was performed at a 1048-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jae-Min, Yang, Kyung-Sook, Chung, You-Seung, Lee, Ki-Byung, Kim, Jeong-Yeon, Kim, Sun-Bean, Sohn, Jang-Wook, Yoon, Young-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388669/
https://www.ncbi.nlm.nih.gov/pubmed/34438953
http://dx.doi.org/10.3390/antibiotics10080903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388669/
https://www.ncbi.nlm.nih.gov/pubmed/34438953
http://dx.doi.org/10.3390/antibiotics10080903

Ejemplares similares